26th Nov 2009 09:28
26 November 2009
Akers Biosciences Inc.
("ABI or the "Company")
Holdings in Company
Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, received notification on 25 November 2009 that Legal & General Group plc, or its subsidiaries ("Legal & General"), purchased 500,000 Common Shares of nil par value in the Company on 24 November 2009. Following this transaction Legal & General's total interest in the Company is 7,300,000 Common Shares, representing approximately 6.4 per cent. of the Company's issued share capital.
Enquiries:
Thomas A. Nicolette
President and CEO
Tel. +1 856 848 8698
Ben SimonsM: CommunicationsTel. +44 (0)20 7920 2340
Alasdair Younie/Ben Wells
Arbuthnot Securities Limited
Tel. +44 (0)20 7012 2000
Related Shares:
AKR.LLegal & General